Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

2.

For the first time in humans, a chemotherapy drug reaches the brain.

3.

Belgian Algorithm Reshapes Endometrial Cancer Care

4.

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

5.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot